These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33368777)

  • 1. Motivators of and barriers to becoming a COVID-19 convalescent plasma donor: A survey study.
    Masser BM; Ferguson E; Thorpe R; Lawrence C; Davison TE; Hoad V; Gosbell IB
    Transfus Med; 2021 Jun; 31(3):176-185. PubMed ID: 33368777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical contribution in a time of crisis: Examining motivations and deterrents to COVID-19 convalescent plasma donation and future donation intentions among prospective Canadian donors.
    Holloway K; Campbell C; Ali R; Huyer LD; Hart D; Haw J; Brennenstuhl S; Grundy Q
    Transfus Med; 2022 Oct; 32(5):351-365. PubMed ID: 35578828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deterrents in recruitment of COVID-19 convalescent plasma donors: Experience from a hospital-based blood centre in India.
    Dhiman Y; Coshic P; Pandey HC; Khatiwada B; Singh J; Mehta V; Gupta S
    Transfus Med; 2021 Jun; 31(3):149-154. PubMed ID: 33749020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 convalescent plasma donors: Unique motivations in unique times?
    Crowder LA; Steele WR; Goodhue E; Lasky B; Young PP
    Transfusion; 2023 Apr; 63(4):703-710. PubMed ID: 36866426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A trend of dropping anti-SARS-CoV-2 plaque reduction neutralization test titers over time in Canadian convalescent plasma donors.
    Drews SJ; Devine DV; McManus J; Mendoza E; Manguiat K; Wood H; Girardin R; Dupuis A; McDonough K; Drebot M
    Transfusion; 2021 May; 61(5):1440-1446. PubMed ID: 33734448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 Convalescent Plasma: from donation to treatment - A Systematic Review & Single Center Experience.
    Fabricius MM; Dandachi D
    Mo Med; 2021; 118(1):74-80. PubMed ID: 33551490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case Report: Serial Cases: Prolongation of High Immunoglobulin G Level in Repetitive COVID-19 Convalescence Plasma Donor in Saiful Anwar Hospital Malang, Indonesia.
    Nurarifah N; Brahmantyo HP; Wardhani SO; Hermanto DH; Arsana PM
    Front Immunol; 2021; 12():633323. PubMed ID: 34790190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychological assessment and lived experiences of recovered COVID-19 patients who presented for convalescent plasma donation.
    Maheshwari A; Varshney M; Gupta K; Bajpai M
    Transfus Clin Biol; 2021 Aug; 28(3):254-257. PubMed ID: 33895379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of a pilot program for COVID-19 convalescent plasma collection in Wuhan, China.
    Li L; Yang R; Wang J; Lv Q; Ren M; Zhao L; Chen H; Xu H; Xie S; Xie J; Lin H; Li W; Fang P; Gong L; Wang L; Wu Y; Liu Z
    Transfusion; 2020 Aug; 60(8):1773-1777. PubMed ID: 32491199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening donors for COVID-19 convalescent plasma.
    Wang HE; Ostrosky-Zeichner L; Katz J; Wanger A; Bai Y; Sridhar S; Patel B
    Transfusion; 2021 Apr; 61(4):1047-1052. PubMed ID: 33368395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constraints and challenges in convalescent plasma collection amidst the Covid 19 pandemic- strategies and recommendations to overcome these.
    Mahapatra S; Pati S
    Transfus Clin Biol; 2021 May; 28(2):175-179. PubMed ID: 33677086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring predictors of Australian community members' blood donation intentions and blood donation-related behavior during the COVID-19 pandemic.
    Masser BM; Hyde MK; Ferguson E
    Transfusion; 2020 Dec; 60(12):2907-2917. PubMed ID: 32905630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and serological patterns of COVID-19 convalescent plasma donors: optimal donors and timing of donation.
    Li L; Tong X; Chen H; He R; Lv Q; Yang R; Zhao L; Wang J; Xu H; Liu C; Chen G; Chen S; Li C; Qiao J; Yang J; Wu Y; Liu Z
    Transfusion; 2020 Aug; 60(8):1765-1772. PubMed ID: 32627216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of SARS-CoV-2 among potential convalescent plasma donors and analysis of their deferral pattern: Experience from tertiary care hospital in western India.
    Jain R; Mallya MV; Amoncar S; Palyekar S; Adsul HP; Kumar R; Chawla S
    Transfus Clin Biol; 2022 Feb; 29(1):60-64. PubMed ID: 34302953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood donation in times of crisis: Early insight into the impact of COVID-19 on blood donors and their motivation to donate across European countries.
    Chandler T; Neumann-Böhme S; Sabat I; Barros PP; Brouwer W; van Exel J; Schreyögg J; Torbica A; Stargardt T
    Vox Sang; 2021 Nov; 116(10):1031-1041. PubMed ID: 33835509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioethical perspective of convalescent plasma therapy for COVID-19: A systematic review.
    Munir MA; Tandiabang PA; Setyawati T; Basry A; Cyio AD; Rahman N
    Transfus Clin Biol; 2021 Aug; 28(3):271-275. PubMed ID: 33839300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 neutralizing capacity among blood donors without prior COVID-19 symptomatic history vs. blood donors with prior COVID-19 symptomatic history: A comparative study.
    Ravula U; Chunchu SR; Mooli S; Naik R; Sarangapati PRR
    Transfus Clin Biol; 2022 May; 29(2):107-111. PubMed ID: 35167958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of collecting and processing of COVID-19 convalescent plasma for treatment of COVID-19 in Uganda.
    Muttamba W; Lusiba J; Namakula LO; Byakika-Kibwika P; Ssali F; Ddungu H; Mugenyi L; Kiwanuka N; Sekibira R; Kityo C; Keyune D; Acana S; Musinguzi A; Masasi A; Byamugisha J; Mpanju D; Musoki WJ; Tukamuhebwa HA; Nakwagala F; Bagaya BS; Kayongo A; Kimuli I; Nantanda R; Katagira W; Buregyeya E; Byanyima R; Byarugaba B; Siddharthan T; Mwebesa H; Charles O; Joloba ML; Bazeyo W; Kirenga B
    PLoS One; 2021; 16(6):e0252306. PubMed ID: 34138909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective study assessing the characteristics of COVID-19 convalescent plasma donors and donations.
    Del Fante C; Franchini M; Baldanti F; Percivalle E; Glingani C; Marano G; Mengoli C; Mortellaro C; Viarengo G; Perotti C; Liumbruno GM
    Transfusion; 2021 Mar; 61(3):830-838. PubMed ID: 33231325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors related to the development of high antibody titres against SARS-CoV-2 in convalescent plasma donors from the ConPlas-19 trial.
    Romera Martínez I; Avendaño-Solá C; Villegas Da Ros C; Bosch Llobet A; García Erce JA; González Fraile MI; Guerra Domínguez L; Vicuña Andrés I; Anguita Velasco J; González Rodríguez VP; Contreras E; Urcelay Uranga S; Pajares Herraiz ÁL; Jimenez-Marco T; Ojea Pérez AM; Arroyo Rodríguez JL; Pérez-Olmeda M; Ramos-Martínez A; Velasco-Iglesias A; Bueno Cabrera JL; Duarte RF
    Vox Sang; 2024 Jan; 119(1):27-33. PubMed ID: 37986640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.